In this post, we’ll shift our focus from formulation to a crucial topic: Artwork Management in Pharma.
In the pharmaceutical industry, managing artwork for product packaging is essential to ensure compliance, accuracy, and maintaining the brand’s standards. Here’s a detailed look at the process:
Initiating the Artwork Request
The process begins when a new artwork is required or changes need to be made due to updates in regulations, product details, or marketing. This request typically comes from the Marketing Department or Regulatory Affairs.
Gathering Key Information
he Marketing Department and Regulatory Affairs collect all necessary information, including:
-Product information (pack size, design, text)
-Regulatory requirements
-Technical details from the Quality Assurance (QA) team
Creating the Initial Design
An artist or design studio creates a draft based on the provided specifications. If foreign languages are involved, the regulatory department ensures the correct localization of text.
Cross-Department Review
The draft artwork is reviewed by multiple departments (R&D, Production, QA and Marketing). This ensures the design, text, and format meet all technical, regulatory, and marketing standards.
Final Approval
After revisions and corrections, the artwork receives final approval from the Head of Quality Assurance, ensuring that it’s ready for production.
Quality Checks & Production
Once approved, the artwork is sent to the production team for printing. Quality checks are performed on the printed packaging materials to ensure they align with the final approved artwork.
Managing Changes
For any updates or changes, a formal change control process is followed to track and document revisions. This ensures transparency and avoids any mistakes during production.
By following these steps, pharmaceutical companies can ensure that packaging is accurate, compliant with regulations, and consistently represents the brand.
Read also:
- Pharmaceutical QA for Packaging and Labeling Controls
- Guidelines on Packaging for Pharmaceutical Products | Part I
Resource Person: Jamal Jameel